查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1933296

全球Tramadol市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Tramadol Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

Tramadol市场成长驱动因素

2025年全球Tramadol市场规模达到23.4亿美元，并预计从2026年的24.7亿美元成长至2034年的39.7亿美元，在预测期（2026-2034年）内年复合成长率（CAGR）为6.09%。北美地区在2025年占据市场主导地位，市场占有率达50.26%，这主要得益于该地区慢性疼痛疾病的高发生率、先进的医疗保健基础设施以及强大的药品分销网路。

Tramadol是一种合成鸦片类镇痛药，广泛用于治疗与慢性疾病、术后、癌症、神经性疾病、牙科疾病和肌肉骨骼损伤相关的轻度至中度疼痛。与更强效的鸦片类药物相比，Tramadol疗效显着、剂型多样且滥用风险较低，因此在临床上已广泛应用。

市场概览

全球疼痛相关疾病的增加是推动Tramadol需求的主要因素。根据世界卫生组织（WHO）统计，全球有 5.28亿人患有骨关节炎，自 1990年以来病例增加了 113%。这显着增加了对疼痛管理疗法的需求。Tramadol因其疗效和耐受性均衡而广泛用于治疗急性和慢性疼痛。

在 COVID-19 疫情期间，由于择期手术和门诊就诊量减少，市场暂时放缓。然而，到2022年，处方量恢復到疫情前水准，并在2034年前保持缓慢但稳定的成长，这主要得益于外科手术量的增加和慢性病患病率的上升。

市场驱动因素

慢性疼痛疾病盛行率上升

癌症、骨关节炎、心血管疾病和肾臟病等慢性疾病发生率的上升，推动对疼痛管理药物的长期需求。当非鸦片类止痛药不足以缓解中度疼痛时，Tramadol通常被推荐用于治疗中度疼痛，尤其适用于需要长期治疗的患者。

研发活动不断扩大

製药公司加大研发投入，开发新的Tramadol组合和製剂，目的是提高疗效并减少副作用。针对新适应症的临床试验增加以及监管部门批准范围的扩大，扩大Tramadol在多种疼痛类别中的治疗范围。

市场限制

儘管Tramadol具有临床疗效，但其市场仍面临副作用和监管方面的限制。噁心、头晕、抽搐、呼吸抑制和成瘾风险等副作用限制了其使用，尤其是在儿童和高风险族群中。一些国家对阿片类药物处方的监管限制也可能限制市场扩张。

市场趋势

联合疗法监管审批不断增加

影响市场的显着趋势是含有Tramadol的多药镇痛药的核准。这些联合疗法目的是减少鸦片类药物的剂量，同时保持有效的镇痛效果。例如，Tramadol复方製剂和联合疗法的批准有助于提高安全性并扩大临床应用。

市场区隔分析

依剂型划分

市场依剂型划分：锭剂、胶囊、注射剂及其他。

预计2026年，锭剂将占据市场主导地位，市场占有率达40.92%，主要得益于其给药方便、成本效益高，以及速释和缓释製剂的供应。胶囊和注射剂也呈现稳定成长，这主要归功于其生物利用度的提高以及在急性护理环境中快速缓解疼痛的效果。

依通路划分

预计到2026年，医院药局将占据最大的市场占有率（56.42%），这主要得益于住院患者数量的增加以及术后疼痛管理需求的成长。零售药房和线上药房因其更高的可及性和便利性而备受关注。

区域概览

到2025年，北美市场规模将达到 11.8亿美元，主要受高癌症发病率和疼痛管理疗法普及的推动。

欧洲占据了较大的市场占有率，其中德国和英国呈现稳定成长，这得益于强大的製药生产和研发投入。

由于人口老化以及中国、日本和印度外科手术量的增加，亚太地区预计将稳定扩张。

拉丁美洲以及中东和非洲预计将以适度的速度成长，主要受医疗保健服务可近性提高和疼痛管理意识增强的推动。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 各国及地区主要慢性病盛行率（2025年）
  • 主要产业趋势：併购、合作等
  • 产品线分析
  • 新冠疫情对Tramadol市场的影响

第5章 全球Tramadol市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依剂型划分
    • 片剂
    • 胶囊
    • 注射剂
    • 其他
  • 市场分析、洞察与预测：依销售管道划分
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美Tramadol市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国各州
    • 加拿大

第7章 欧洲Tramadol市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第8章 亚太地区Tramadol市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他亚太地区国家

第9章 拉丁美洲Tramadol市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第10章 中东与非洲Tramadol市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南非
    • 其他中东和非洲国家

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • Grunenthal
    • Mundipharma International
    • Zydus Group
    • GSK plc
    • Vertical Pharmaceuticals
    • Janssen Global Services, LLC
    • Cipher Pharmaceuticals Inc.
Product Code: FBI109499

Growth Factors of tramadol Market

The global tramadol market was valued at USD 2.34 billion in 2025 and is projected to grow from USD 2.47 billion in 2026 to USD 3.97 billion by 2034, registering a CAGR of 6.09% during the forecast period (2026-2034). North America dominated the market in 2025 with a 50.26% share, supported by a high prevalence of chronic pain conditions, advanced healthcare infrastructure, and strong pharmaceutical distribution networks.

Tramadol is a synthetic opioid analgesic widely used to manage mild to moderately severe pain associated with chronic diseases, post-operative procedures, cancer, neuropathic disorders, dental conditions, and musculoskeletal injuries. Its effectiveness, multiple dosage forms, and comparatively lower abuse potential than stronger opioids have contributed to its widespread adoption in clinical practice.

MARKET OVERVIEW

The growing global burden of pain-related disorders is a major factor driving tramadol demand. According to the World Health Organization, 528 million people globally were affected by osteoarthritis, with cases rising by 113% since 1990, significantly increasing the need for pain management therapies. Tramadol is commonly prescribed due to its balanced efficacy and tolerability profile, making it suitable for both acute and chronic pain conditions.

During the COVID-19 pandemic, the market experienced a temporary slowdown due to reduced elective surgeries and outpatient visits. However, by 2022, prescription volumes recovered to pre-pandemic levels, and the market is expected to maintain moderate but steady growth through 2034, supported by rising surgical volumes and chronic disease prevalence.

MARKET DRIVERS

Rising Prevalence of Chronic Pain Conditions

The increasing incidence of chronic diseases such as cancer, osteoarthritis, cardiovascular disorders, and renal diseases is driving long-term demand for pain management drugs. Tramadol is frequently recommended when non-opioid analgesics fail to provide adequate relief, especially for moderate pain requiring extended treatment.

Growth in Research and Development Activities

Pharmaceutical companies are investing in R&D to develop novel tramadol combinations and formulations aimed at improving efficacy and reducing adverse effects. Increased clinical trials and regulatory approvals for new indications are expanding the therapeutic scope of tramadol across multiple pain categories.

MARKET RESTRAINTS

Despite its clinical benefits, the tramadol market faces restraints related to adverse effects and regulatory scrutiny. Side effects such as nausea, dizziness, seizures, respiratory depression, and dependency risks limit usage, particularly among pediatric and high-risk populations. Regulatory restrictions on opioid prescriptions in several countries may also constrain market expansion.

MARKET TRENDS

Increasing Regulatory Approvals for Combination Therapies

A prominent trend shaping the market is the approval of multimodal analgesic combinations that include tramadol. These combinations aim to reduce opioid dosage while maintaining effective pain relief. For instance, approvals for tramadol-based co-crystal and combination therapies are improving safety outcomes and expanding clinical adoption.

SEGMENTATION ANALYSIS

By Dosage Form

Based on dosage form, the market is segmented into tablets, capsules, injections, and others.

The tablets segment dominated the market in 2026 with a 40.92% share, driven by ease of administration, cost-effectiveness, and availability in immediate-release and extended-release formulations. Capsules and injections are also witnessing steady growth due to improved bioavailability and faster pain relief in acute care settings.

By Distribution Channel

By distribution channel, hospital pharmacies held the largest market share in 2026 (56.42%), supported by high inpatient admissions and post-surgical pain management needs. Retail and online pharmacies are gaining traction due to improved accessibility and patient convenience.

REGIONAL INSIGHTS

North America generated USD 1.18 billion in 2025, driven by high cancer prevalence and widespread access to pain management therapies.

Europe held a significant share, supported by strong pharmaceutical manufacturing and R&D initiatives, with Germany and the UK showing stable growth.

Asia Pacific is expected to witness steady expansion due to aging populations and increasing surgical procedures in China, Japan, and India.

Latin America and the Middle East & Africa are anticipated to grow at a moderate pace due to improving healthcare access and rising awareness of pain management.

COMPETITIVE LANDSCAPE

The tramadol market is moderately fragmented, with key players such as Grunenthal, Zydus Group, GSK plc, Mundipharma International, and Janssen Global Services holding notable market positions. These companies focus on strategic partnerships, regulatory approvals, and new formulation launches to strengthen their global presence.

CONCLUSION

The global tramadol market is positioned for steady growth, driven by the rising prevalence of chronic pain conditions, increasing surgical procedures, and continuous advancements in drug formulations. With the market expanding from USD 2.34 billion in 2025 to USD 3.97 billion by 2034, growing R&D investments, regulatory approvals for combination therapies, and expanding access to pain management solutions are expected to sustain demand. Although concerns related to side effects and opioid regulations persist, tramadol's balanced efficacy profile ensures its continued relevance in global pain management strategies during the forecast period.

Segmentation By Dosage Form

  • Tablets
  • Capsules
  • Injections
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (By Dosage Form, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. Pipeline Analysis
  • 4.4. Impact of COVID-19 on the Tramadol Market

5. Global Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 5.1.1. Tablets
    • 5.1.2. Capsules
    • 5.1.3. Injections
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.2.1. Hospital Pharmacies
    • 5.2.2. Retail Pharmacies
    • 5.2.3. Online Pharmacies
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 6.1.1. Tablets
    • 6.1.2. Capsules
    • 6.1.3. Injections
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.2.1. Hospital Pharmacies
    • 6.2.2. Retail Pharmacies
    • 6.2.3. Online Pharmacies
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 7.1.1. Tablets
    • 7.1.2. Capsules
    • 7.1.3. Injections
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.2.1. Hospital Pharmacies
    • 7.2.2. Retail Pharmacies
    • 7.2.3. Online Pharmacies
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Rest of Europe

8. Asia Pacific Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 8.1.1. Tablets
    • 8.1.2. Capsules
    • 8.1.3. Injections
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Retail Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Rest of Asia Pacific

9. Latin America Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 9.1.1. Tablets
    • 9.1.2. Capsules
    • 9.1.3. Injections
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.2.1. Hospital Pharmacies
    • 9.2.2. Retail Pharmacies
    • 9.2.3. Online Pharmacies
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Tramadol Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Dosage Form
    • 10.1.1. Tablets
    • 10.1.2. Capsules
    • 10.1.3. Injections
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.2.1. Hospital Pharmacies
    • 10.2.2. Retail Pharmacies
    • 10.2.3. Online Pharmacies
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.3.1. GCC
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Grunenthal
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Mundipharma International
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Zydus Group
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. GSK plc
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Vertical Pharmaceuticals
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Janssen Global Services, LLC
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Cipher Pharmaceuticals Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 2: Global Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 3: Global Tramadol Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 4: North America Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 5: North America Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 6: North America Tramadol Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 7: Europe Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 8: Europe Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 9: Europe Tramadol Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 11: Asia Pacific Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 12: Asia Pacific Tramadol Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 14: Latin America Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Latin America Tramadol Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Tramadol Market Revenue (USD billion) Forecast, by Dosage Form, 2021-2034
  • Table 17: Middle East & Africa Tramadol Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 18: Middle East & Africa Tramadol Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Tramadol Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Tramadol Market Value Share (%), by Dosage Form, 2025 & 2034
  • Figure 3: Global Tramadol Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 4: Global Tramadol Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Tramadol Market Value (USD billion), by Dosage Form, 2025 & 2034
  • Figure 6: North America Tramadol Market Value Share (%), by Dosage Form, 2025
  • Figure 7: North America Tramadol Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 8: North America Tramadol Market Value Share (%), by Distribution Channel, 2025
  • Figure 9: North America Tramadol Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Tramadol Market Value Share (%), By Country, 2025
  • Figure 11: Europe Tramadol Market Value (USD billion), by Dosage Form, 2025 & 2034
  • Figure 12: Europe Tramadol Market Value Share (%), by Dosage Form, 2025
  • Figure 13: Europe Tramadol Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: Europe Tramadol Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: Europe Tramadol Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Tramadol Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Tramadol Market Value (USD billion), by Dosage Form, 2025 & 2034
  • Figure 18: Asia Pacific Tramadol Market Value Share (%), by Dosage Form, 2025
  • Figure 19: Asia Pacific Tramadol Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 20: Asia Pacific Tramadol Market Value Share (%), by Distribution Channel, 2025
  • Figure 21: Asia Pacific Tramadol Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Tramadol Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Tramadol Market Value (USD billion), by Dosage Form, 2025 & 2034
  • Figure 24: Latin America Tramadol Market Value Share (%), by Dosage Form, 2025
  • Figure 25: Latin America Tramadol Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 26: Latin America Tramadol Market Value Share (%), by Distribution Channel, 2025
  • Figure 27: Latin America Tramadol Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Tramadol Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East & Africa Tramadol Market Value (USD billion), by Dosage Form, 2025 & 2034
  • Figure 30: Middle East & Africa Tramadol Market Value Share (%), by Dosage Form, 2025
  • Figure 31: Middle East & Africa Tramadol Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 32: Middle East & Africa Tramadol Market Value Share (%), by Distribution Channel, 2025
  • Figure 33: Middle East & Africa Tramadol Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Tramadol Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Tramadol Market Share (%), By Company, 2025